back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-10 10:55 Tx date 2025-01-09 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,000
+20,000 vol $1.45 each |
40,000 | |
| Filed 2024-09-30 14:50 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2024-01-16 17:03 Tx date 2024-01-15 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2023-08-30 10:09 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
930,000 | |
| Filed 2023-01-19 16:59 Tx date 2023-01-18 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,143
+70,000 vol $0.1449 each |
315,000 | |
| Filed 2022-10-19 16:39 Tx date 2022-10-18 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
245,000 | |
| Filed 2022-06-03 10:38 Tx date 2022-06-03 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,242
+70,000 vol $0.1606 each |
195,000 | |
| Filed 2021-04-05 10:24 Tx date 2021-04-01 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+730,000 vol |
730,000 | |
| Filed 2021-04-05 10:23 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-01 18:22 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
62,500 | ||
| Filed 2021-04-01 18:21 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2017-03-22 Tx date 2017-03-21 |
$HAW
HAW Capital Corp. |
Hyman, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2017-03-22 Tx date 2016-11-29 |
$HAW
HAW Capital Corp. |
Hyman, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-22 Tx date 2016-11-29 |
$HAW
HAW Capital Corp. |
Hyman, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
630,000 |